Schroder Investment Management Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.57M | Buy |
79,126
+13,010
| +20% | +$423K | ﹤0.01% | 878 |
|
2025
Q1 | $4.59M | Buy |
66,116
+21,298
| +48% | +$1.48M | ﹤0.01% | 770 |
|
2024
Q4 | $3.67M | Buy |
44,818
+30,444
| +212% | +$2.5M | ﹤0.01% | 829 |
|
2024
Q3 | $1.63M | Hold |
14,374
| – | – | ﹤0.01% | 967 |
|
2024
Q2 | $1.09M | Hold |
14,374
| – | – | ﹤0.01% | 1017 |
|
2024
Q1 | $982K | Buy |
+14,374
| New | +$982K | ﹤0.01% | 1030 |
|